ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (The heterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
BRUE — быстро разрешившиеся необъяснимые события (Brief resolved unexplained events)
BSEP — насос выведения солей желчных кислот
CADASIL — церебральная аутосомно-доминантная артериопатия с подкорковыми инфарктами и лейкоэнцефалопатией (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа
PCSK-9 — пропротеиновая конвертаза субтилизин-кекси-нового типа 9 (proprotein convertase subtilisin/ kexin type 9)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода во вдыхаемом
воздухе
рO2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque ... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
RePEAT— пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«-» — резус-отрицательн(ый)
Rh«+» — резус-положительн(ый)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
RR — относительный риск (relative risk или risk ratio) RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом SatO2 — насыщение крови кислородом
ScvO2 — насыщение кислородом центральной венозной крови (Central venous oxygen saturation)
aDG-RD — дистрофии, связанные с a-дистрогликанами (alpha dystroglycan-related dystrophies)
β-ХГЧ — β-субъединица хорионического гонадотропина человека
В ходе подготовки статей по детской офтальмологии в педиатрии для пользователей сайта МедУнивер использованы труды следующих авторов:
Archer SM, Sondhi N, Helveston EM. Strabismus in infancy. Ophthalmology. 96:133–137, 1989.
Emerson MV, Pieramici DJ, Stoessel KM, et al. Incidence and rate of disappearance of retinal hemorrhage in newborns, Ophthalmology. 108:33–39, 2001.
Isenberg SJ, Apt L, McCarty J. Development of tearing in preterm and term infants. Arch Ophthalmol. 1998;116:773–776.
Khodadoust AA, Ziai M, Biggs SL. Optic disc in normal newborns. Am J Ophthalmol. 1968;66:502–504.
Krishnamohan VK, Wheeler MB, Testa MA, et al. Correlation of postnatal regression of the anterior vascular capsule of the lens to gestational age. J Pediatr Ophthalmol Strabismus. 1982;19:28–32.
Roarty JD, Keltner JL. Normal pupil size and anisocoria in newborn infants. Arch Ophthalmol. 1990;108:94–95.
Spieres A, Isenberg SJ, Inkelis SH. Characteristics of the iris in 100 neonates. J Pediatr Ophthalmol Strabismus. 1989;26:28–30.
Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. American Association of Certified Orthoptists; American Association for Pediatric Ophthalmology and Strabismus; American Academy of Ophthalmology. Eye examination in infants, children, and young adults by pediatricians. Pediatrics. 2003;111:902–907.
Donahue SP, Baker CN, et al. Visual system assessment in infants, children, and young adults by pediatricians. Pediatrics. 2016;137(1):28–30.
Donahue SP, Johnson TM, Ottar W, et al. Sensitivity of photoscreening to detect high-magnitude amblyogenic factors. J AAPOS. 2002;6:86–91.
Fulton A. Screening preschool children to detect visual and ocular disorders. Arch Ophthalmol. 1992;110:1553–1554.
Isenberg SJ. Clinical application of the pupil examination in neonates. J Pediatr. 1991;118:650–652.
Salcido AA, Bradley J, Donahue SP. Predictive value of photoscreening and traditional screening of preschool children. J AAPOS. 2005;9:114–120.
Solebo AL, Cumberland PM, Rahi JS. Whole-population vision screening in children aged 4–5 years to detect amblyopia. Lancet. 2015;385(6):2308–2318.
Bastawrous A, Silvester A, Batterbury M. Laser refractive eye surgery. BMJ. 2011;342:d2345.
Brown NP, Koretz JF, Bron AJ. The development and maintenance of emmetropia. Eye (Lond). 1999;13:83–92.
Ding X, Wang D, Huang Q, et al. Distribution and heritability of peripheral eye length in Chinese children and adolescents: the Guangzhou Twin Eye Study. Invest Ophthalmol Vis Sci. 2013;54:1048–1053.
French AN, Morgan IG, Burlutsky G, et al. Prevalence and 5- to 6-year incidence and progression of myopia and hyperopia in Australian schoolchildren. Ophthalmology. 2013;120(7):1482–1491.
Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children. Ophthalmology. 2016;123(4):697–708.
Kleinstein RN, Sinnott LT, Jones-Jordan LA, et al. New cases of myopia in children. Arch Ophthalmol. 2012;130:1274–1279.
Klimek DL, Cruz OA, Scott WE, et al. Isoametropic amblyopia due to high hyperopia in children. J AAPOS. 2004;8:310–313.
Kuo A, Sinatra RB, Donahue SP. Distribution of refractive error in healthy infants. J AAPOS. 2003;7:174–177.
Larsson EK, Rydberg AC, Holmstrom GE. A population-based study of the refractive outcome in 10-year-old preterm and full-term children. Arch Ophthalmol. 2003;121:1430–1436.
Mayer DL, Hansen RM, Moore BD, et al. Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol. 2001;119:1625–1628.
Morgan IG, Ohno-Matusi K, Saw SM. Mypoia. Lancet. 2012;379:1739–1746.
Paysse EA, Coats DK, Hussein MA, et al. Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children. Ophthalmology. 2006;113:169–176.
Stahl ED. Pediatric refractive surgery. Pediatr Clin North Am. 2014;61:519–527.
Ton Y, Wysenbeek YS, Spierer A. Refractive error in premature infants. J AAPOS. 2004;8:534–538.
Dutton G, Cleary M. Should we be screening for and treating amblyopia?,Br Med J. 2003;327:1242–1243.
Olitsky SE, Nelson LB. Reading disorders in children. Pediatr Clin North Am. 2003;50:213–224.
Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268–278.
Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075–2087.
Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603–611.
Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123:437–447.
Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007;125:655–659.
Rahl JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003;362:1359–1364.
Shaywitz SE, Shaywitz BA. The science of reading and dyslexia. J AAPOS 2003;7:158–166.
Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol. 2005;50:123–166.
Bremmer FD, Smith SE. Bilateral tonic pupils: Holmes-Adie syndrome or generalized neuropathy? Br J Ophthalmol. 2007;91:1620–1623.
Chandra A, Aragon-Martin JA, Hughes K, et al. A genotype-phenotype comparison of ADAMTSL4 and FBN1 in isolated ectopia lentis. Invest Ophthalmol Vis Sci. 2012;53:4889–4896.
Cross HE. Ectopia lentis et pupillae. Am J Ophthalmol. 1979;88:381–384.
Frank JW, Kushner BJ, France TD. Paradoxic pupillary phenomenon: A review of patients with pupillary constriction to darkness. Arch Ophthalmol. 1988;106:1564–1566.
Greenwald MJ, Folk ER. Afferent pupillary defects in amblyopia. J Pediatr Ophthalmol Strabismus. 198320:63–67.
Loewenfeld IE: Simple, central” anisocoria: A common condition seldom recognized. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:832.
Lopez J, Fisher PG. The eyes have it: the significance of unilateral ptosis. J Pediatr. 2012;160:703–704.
Maloney WF, Younge BR, Moyer NJ. Evaluation of the causes and accuracy of pharmacologic localization in Horner syndrome. Am J Ophthalmol. 1980;90:394–402.
Miller NR, Newman NJ, Biousse V, et al. Walsh and Hoyt’s clinical neuro-ophthalmology: the essentials. Philadelphia: Lippincott, Williams & Wilkins, 2008:299–301.
Nolano M, Provitera V, Perretti A, et al. Ross syndrome: a rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects. Brain. 2006;129:2119–2131.
Rennie IG. Don’t it make my blue eyes brown: heterochromia and other abnormalities of the iris. Eye (Lond). 2012;26:29–50.
Thompson HS. Segmental palsy of the iris sphincter in Adie’s syndrome. Arch Ophthalmol. 1978;96:1615–1620.
Abroms AD, Mohney BG, Rush DP, et al. Timely surgery in intermittent and constant exotropia for superior sensory outcome. Am J Ophthalmol. 2001;131:111–116.
Hertle RW. Nystagmus in infancy and childhood: characteristics and evidence for treatment. Am Orthopt J. 2010;60:48–58.
Holmes JM, Mutyala S, Maus TL, et al. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol. 1999;127:388–392.
Ing M. Early surgical alignment for congenital esotropia. Ophthalmology. 1983;90:132–135.
Kakisaka Y, Hino-Fukuyo N, Miyazaki H, et al. Infantile tullio phenomenon. J Pediatr. 2013;162:880.
Lambert SR, Lynn M, Sramek J, et al. Clinical features predictive of successfully weaning from spectacles those children with accommodative esotropia. J AAPOS. 2003;7:7–13.
Mohney BG, Huffaker RK. Common forms of childhood exotropia. Ophthalmology. 2003;110:2093–2096.
Morris RJ, Scott WE, Dickey CF. Fusion after surgical alignment of longstanding strabismus in adults. Ophthalmology. 1993;100:135–137.
Olitsky SE, Nelson LB. Strabismus disorders. In Nelson LB, Olitsky SE, editors. Harley’s pediatric ophthalmology. Еd 6. Philadelphia: Lippincott Williams & Wilkins, 2014:140–168.
Pediatric Eye Disease Investigator Group. Spontaneous resolution of early-onset esotropia: experience of the congenital esotropia observational study. Am J Ophthalmol. 2002;133:109–118.
Strominger M. Nystagmus. In Nelson LB, Olitsky SE, editors. Harley’s pediatric ophthalmology. Еd 5. Philadelphia: Lippincott Williams & Wilkins, 2005 475–507.
Yam JC, Chong GS, Wu PK, et al. Preoperative factors predicting the surgical response of bilateral lateral rectus recession surgery in patients with infantile exotropia. J Pediatr Ophthalmol Strabismus. 2013;50:245–250.
Dray JP, Leibovitch I. Congenital ptosis and amblyopia: a retrospective study of 130 cases, J Pediatr Ophthalmol Strabismus.. 2002;39:222–225.
Gusek-Schneider GC, Martus P. Stimulus deprivation amblyopia in human congenital ptosis: a study of 100 patients. Strabismus. . 2000;8:261–270.
Meisler DM, Raizman MB, Traboulsi EI. Oral erythromycin treatment for childhood blepharokeratitis. J AAPOS. 2000;4:379–380.
Nassiri N, Rootman J, Rootman DB, et al. Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol. . 2015;60(5):383–405.
Parikh SR, Darrow DH, Grimmer JF, et al. Propranolol use for infantile hemangiomas.American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns. JAMA Otolaryngol Head Neck Surg. 2013;139:153–156.
Plager DA, Snyder SK. Resolution of astigmatism after surgical resection of capillary hemangiomas in infants. Ophthalmology. 1997;104:1102–1106.
American Academy of Ophthalmology Basic and Clinical Science Course. Section 8: External Disease and Cornea 2011–2012:65–75.
Frick KD, Hariharan L, Repka MX, et al. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants. Arch Ophthalmol. 2011;129:603–609.
Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology. 2008;115(3):577–584.
Pediatric Eye Disease Investigator Group.Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS. 2008;12(5):445–450.
Pediatric Eye Disease Investigator Group. A random trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol. 2012;130:1525–1533.
Schnall BM, Christian CJ. Conservative treatment of congenital dacryocele. J Pediatr Ophthalmol Strabismus. 1996;33:219–222.
Wong RK, VanderVeen DK. Presentation and management of congenital dacryocystocele. Pediatrics. 2008;122(5):1108–1112.
Atik B, Thanh TTK, Luong VQ, et al. Impact of annual targeted treatment of infectious trachoma and susceptibility to reinfection. JAMA. 2006;296:1488–1497.
Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310:1721–1728.
Centers for Disease Control and Prevention. Outbreak of bacterial conjunctivitis at a college — New Hampshire, January–March, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:205–208.
Centers for Disease Control and Prevention. Adenovirus-associated epidemic keratoconjunctivitis outbreaks — four states, 2008–2010. MMWR Morb Mortal Wkly Rep. 2013;32:637–640.
Everitt HA, Little PS, Smith PWF. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ. 2006;333:321–324.
Finn LE, Gutowski J, Alles S, et al. Photokeratitis linked metal halide bulbs in two gymnasiums — Philadelphia, Pennsylvanis, 2011 and 2013. MMWR Morb Mortal Wkly Rep. 2016;65(11):282–284.
Gower EW. Solving the trachoma elimination puzzle, one piece at a time. Lancet. 2012;379:102–103.
Haring RS, Sheffield ID, Frattaroli S. Detergent pod-related eye injuries among preschool-aged children. JAMA Ophthalmol. 2017;135(3):283–284.
Massey J, Henry R, Minnich L, et al. Health care-associated outbreak of epidemic keratoconjunctivitis—West Virginia, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(14):382–383.
O’Brien TP. Allergic conjunctivitis: an update on diagnosis and management. Curr Opin Allergy Clin Immunol. 2013;13:543–549.
Rietveld RP, ter Riet G, Bindels PJE, et al. Predicting bacterial cause in infectious conjunctivitis: Cohort study on informativeness of combinations of signs and symptoms. BMJ. 2004;329:206–208.
Sauer A, Bourcier T. French Study Group for Contact Lenses Related Keratitis. Acta Ophthalmol. 2011;89:e439–e442.
Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis (review). Cochrane Database Syst Rev. 2012;(9):CD001211.
Shiuey Y, Ambati BK, Adamis AP and the Viral Conjunctivitis Study Group: A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology. 2000;107:1512–1517.
Williams L, Malhotra Y, Murante B, et al. A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children. J Pediatr. 2013;162:857–861.
Comer RM, Daya SM, O’Keefe M. Penetrating keratoplasty in infants. J AAPOS, 2001;5:285–290.
Cope JR, Collier SA, Srinivasan K, et al. Contact lens related corneal infections — United States, 2005–2015. MMWR. 2016;65(32):817–820.
Dana MR, Moyes AL, Gomes JA, et al. The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology. 1995;102:1129–1138.
Haring RS, Sheffield ID, Channa R, et al. Epidemiologic trends of chemical ocular burns in the United States. JAMA Ophthalmol. 2016;134(10):1119–1124.
Mackey DA, Buttery RG, Wise GM, et al. Description of X-linked megalocornea with identification of the gene locus. Arch Ophthalmol. 1991;109:829–833.
Mohandessan MM, Romano PE. Neuroparalytic keratitis in Goldenhar-Gorlin syndrome. Am J Ophthalmol. 1978;85:111–113.
Nischal KK. Congenital corneal opacities — a surgical approach to nomenclature and classification. Eye (Lond). 2007;21:1326–1337.
Nischal KK. A new approach to the classification of neonatal corneal opacities. Curr Opin Ophthalmol. 2012;23:344–354.
Traboulsi EI, Maumenee IH. Peters’ anomaly and associated congenital malformations. Arch Ophthalmol. 1992;110:1739–1742.
Yang LL, Lambert SR, Fernhoff PM, et al. Peters’ anomaly: Associated congenital malformations and etiology. Invest Ophthalmol Vis Sci. 1995;36:S41.
Yang LL, Lambert SR, Lynn MJ, et al. Long-term results of corneal graft survival in infants and children with Peters anomaly. Ophthalmology. 1999;106:833–848.
Anteby I, Isaac M, BenEzra D. Hereditary subluxated lenses: visual performances and long-term follow-up after surgery. Ophthalmology. 2003;110:1344–1348.
Bhatti TR, Dott M, Yoon PW, et al. Descriptive epidemiology of infantile cataracts in metropolitan Atlanta, GA, 1968–1998. Arch Pediatr Adolesc Med. 2003;157:341–347.
Fallaha N, Lambert SR. Pediatric cataracts. Ophthalmol Clin North Am. 2001;14:479–492.
Plager DA, Lynn MJ, Buckley EG, et al. Complications, adverse events and additional intraocular surgery one year after cataract surgery in the Infant Aphakia Treatment Study. Ophthalmology. 2011;118(12):2330–2334.
Plager DA, Yang S, Neely D, et al. Complications in the first year following cataract surgery with and without IOL in infants and older children. J AAPOS. 2002;6:9–14.
Russell HC, McDougall V, Dutton GN. Congenital cataract. BMJ. 2011;342:d3075.
Russell-Eggit IM: Non-syndromic posterior lenticonus a cause of childhood cataract: evidence for x-linked inheritance. Eye (Lond). 2000;14(Pt 6):861–863.
SanGiovanni JP, Chew EY, Reed GF, et al. Infantile cataract in collaborative perinatal project: prevalence and risk factors. Arch Ophthalmol. 2002;120(11):1559–1565.
Hug D. Pediatric cataracts and lens anomalies. In Nelson LB, Olitsky SE, editors. Harley’s pediatric ophthalmology. Еd 6. Philadelphia: Lippincott Williams & Wilkins, 2014. Р. 238–257.
The Infant Aphakia Treatment Study Group. A randomized clinical trial comparing contact lens to intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol. 2010;128(7):810–818.
BenEzra D, Cohen E. Cataract surgery in children with chronic uveitis. Ophthalmology. 2000;107:1255–1260.
Ferrini W, Aubert V, Balmer A, et al. Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl. Pediatrics. 2013;132:e1035–e1037.
Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135:867–878.
Jaffe GJ, Dick AD, Br?zin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–942.
Kadayifcilar S, Eldem B, Tumer B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40:335–340.
Kempen JH, Altaweel MM, Holbrook JH, et al. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. JAMA. 2017;317(19):1993–2005.
Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545–553.
McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. Lancet. 2004;364:2125–2133.
Nguyen QD, Merrill PT, Jaffee GJ, et al. Adalimumab for prevention of uvetic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicenter, double-masked, randomized, placebo-controlled phase 2 trial. Lancet. 2016;388:1183–1192.
Oren B, Sehgal A, Simon JW, et al. The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS. 2001;5:2–4.
Patel H, Goldstein D. Pediatric uveitis. Pediatr Clin North Am. 2003;50:125–136.
Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299–2306.
Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemo- therapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623–1629.
Bainbridge JWB, Mehat MS, Sundaram V, et al. Long-term effect of gene therapy on Leber’s congenital amaurosis. N Engl J Med. 2015;372(20):1887–1896.
Bennett J, Wellman J, Marshall KA, et al. safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016;388:661–672.
Bonner C, El-Amraoui A. Usher syndrome (sensorineural deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches. Curr Opin Neurol. 2012;25:42–49.
Cavallaro G, Filippi L, Bagnoli P, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014;92(1):2–20.
Chang M, McLean IW, Merritt JC. Coats’ disease: a study of 62 histologically confirmed cases. J Pediatr Ophthalmol Strabismus. 1984;21:163–168.
Cryotherapy for Retinopathy of Prematurity Cooperative Group. 15-year outcomes following threshold retinopathy of prematurity. Arch Ophthalmol. 2005;123:311–318.
Dass AB, Trese MT. Surgical results of persistent hyperplastic primary vitreous. Ophthalmology. 1999;106:280–284.
Di Fiore J, Kaffashi F, Loparo K, et al. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr Res. 2012;72:606–612.
Early Treatment Diabetic Retinopathy Research Study Group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report 1. Arch Ophthalmol. 1985;103:1796–1806.
Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1696.
Ellingford JM, Sergouniotis PI, Lennon R, et al. Pinpointing clinical diagnosis through whole exome sequencing to direct patient care: a case of Senior-Loken syndrome. Lancet. 1916;385:2015.
Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131:189–195.
Filippi L, Cavallaro G, Bagnoli P, et al. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr. 2013;163:1570–1577.
Georgalas I, Kymionis G. Angioid streaks in the fundus of a 13-year-old girl. J Pediatr. 2016;179:269.
George ND, Yates JR, Moore AT. Clinical features in affected males with x-linked retinoschisis. Arch Ophthalmol. 1996;114:274–280.
Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367:2515–2524.
Hellstrom A, Smith LEH, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445–1454.
Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9–24.
Jacobson SG, Cideciyan AV, Roman AJ, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015;372(20):1920–1926.
Kim JW, Abramson DH, Dunkel IJ. Current management strategies for intraocular retinoblastoma. Drugs. 2007;67(15):2173–2185.
Koenekoop RK. Successful RPE65 gene replacement and improved visual function in humans. Ophthalmic Genet. 2008;29(3):89–91.
Koenekoop RK, Sui R, Sallum J, et al. Oral 0-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b tiral. Lancet. 2014;384:1513–1520.
Mactier H, McCulloch DL, Hamilton R, et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. J Pediatr. 2012;160:954–959.
Mintz-Hittner HA, Kennedy KA, Chuang AZ, for the BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–615.
Miyakulo H, Hashimoto K, Miyakulo S. Retinal vascular pattern in familial exudative vitreoretinopathy. Ophthalmology. 1984;91:1524–1530.
Reynolds JD, Hardy RJ, Kennedy KA, et al; for the Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med. 1998;338:1572–1576.
Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1 2 studies. Lancet. 2015;385:509–516.
Screening Examinations of Premature Infants for Retinopathy of Prematurity. Pediatrics. 2006;117:572–576.
Sears JE, Pietz J, Sonnie C, et al. A change in oxygen supplementation can decrease the Incidence of ROP. Ophthalmology. 2009;116(3):513–518.
Shields CL, Gorry T, Shields JA. Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician. J Pediatr Ophthalmol Strabismus. 2004;41:143–149.
Suvarna JC, Hajela SA. Cherry-red spot. J Postgrad Med. 2008;54:54–57.
Watts P, Maguire S, Kwok T, et al. Newborn retinal hemorrhages: a systematic review. J AAPOS. 2013;17:70–78.
Garcia-Filion P, Fink C, Geffner ME, et al. Optic nerve hypoplasia in North America: a re-appraisal of perinatal risk factors. Acta Ophthalmol. 2010;88(5):527–534.
Hickman SJ, Dalton CM, Miller DH, et al. Management of acute optic neuritis. Lancet. 2002;360:1953–1962.
Massaro M, Thorarensen O, Liu GT, et al. Morning glory disc anomaly and moyamoya vessels. Arch Ophthalmol. 1998;116:253–254.
Optic Neuritis Study Group. Visual function 5 years after optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol. 1997;115:1545–1552.
Patra S, Krishnamurthy S, Seth A, et al. Bilateral optic neuritis in pediatric systemic lupus erythematosus with antiphospholipid antibody syndrome. Indian J Pediatr. 2011;78:234–236.
Raftopoulod R, Hickman SJ, Toosy A, et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomized, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:259–269.
Repka MX, Miller NR. Optic atrophy in children. Am J Ophthalmol. 1988;106:191–193.
Rostasy K, Mader S, Schanda K, et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol. 2012;69:752–756.
Skarf B, Hoyt CS. Optic nerve hypoplasia in children: association with anomalies of the endocrine and CNS. Arch Ophthalmol. 1984;102:62–67.
Beck AD, Freedman S, Kammer J, et al. Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life. Am J Ophthalmol. 2003;136:994–1000.
Morad Y, Donaldson CE, Kim YM, et al. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003;135:821–829.
Neely DE, Plager DA. Endocyclophotocoagulation for management of difficult pediatric glaucomas. J AAPOS. 2001;5:221–229.
Sidoti PA, Belmonte SJ, Liebmann JM, et al. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000;107:422–429.
Simon JW, Mehta N, Simmons ST, et al. Glaucoma after pediatric lensectomy/vitrectomy. Ophthalmology. 1991;98:670–674.
Yonekawa Y, VanderVeen DK, Shah AS. Congenital glaucoma. J Pediatr. 2013;163:301.
Gorospe L, Royo A, Berrocal T, et al: Imaging of orbital disorders in pediatric patients, Eur Radiol 13:2012-2026, 2003.
Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37:207–222.
Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111:997–1008.
Yuen SJA, Rubin PAD. Idiopathic orbital inflammation. Arch Ophthalmol. 2003;121:491–499.
Ambati BK, Ambati J, Azar N, et al. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology. 2000;107:1450–1453.
Brouk I. Microbiology and antimicrobial treatment of orbit and intracranial complications of sinusitis in children and their management. Int J Pediatr Otorhinolaryngol. 2009;73:1183–1186.
Garcia GH, Harris GJ. Criteria for nonsurgical management of subperiosteal abscess of the orbit: Analysis of outcomes 1988–1998. Ophthalmology. 2000;107:1454–1456.
Greenberg MF, Pollard ZF. Medical treatment of pediatric subperiosteal orbital abscess secondary to sinusitis. J AAPOS. 1998;2:351–355.
Hoshino A, Fujii T, Hibino S, Abe Y. Acute infantile dacryoadenitis. J Pediatr. 2014;164:425.
Lazzeri D, Lazzeri S, Figus M, et al. Periorbital necrotizing fasciitis. Br J Ophthalmol. 2010;94:1577–1585.
McKinley SH, Yen MT, Miller AM, et al. Microbiology of pediatric orbital cellulitis. Am J Ophthalmol. 2007;144:497–501.
Nageswaran S, Woods CR, Benjamin DK Jr, et al. Orbital cellulitis in children. Pediatr Infect Dis J. 2006;25:695–699.
Peta MT, Preciado D, Orestes M, et al. Orbital complications of acute sinusitis. JAMA Otolaryngol Head Neck Surg. 2013;139:223–227.
Reynolds DJ, Kodsi SR, Rubin SE, Rodgers R. Intracranial infection associated with preseptal and orbital cellulitis in the pediatric patient. J AAPOS. 2003;7:413–417.
American Academy of Pediatrics Committee on Sports Medicine and Fitness, American Academy of Ophthalmology Committee on Eye Safety and Sports Ophthalmology. Protective eyewear for young athletes. Pediatrics. 1996;98:311–313.
Buys YM, Levin AV, Enzenauer RW, et al. Retinal findings after head trauma in infants and young children. Ophthalmology. 1992;99:1718–1723.
Centers for Disease Control and Prevention. Serious eye injuries associated with fireworks — United States, 1990–1994. MMWR Morb Mortal Wkly Rep. 1995;44:449–452.
Crouch ER Jr, Crouch ER. Management of traumatic hyphema: therapeutic options. J Pediatr Ophthalmol Strabismus. 1999;36:238–250.
Dhoot DS, Xu D, Srivastave S. High-powered laser pointer injury resulting in macular hole formation. J Pediatr. 2014;164:668.
Egbert JE, May K, Kersten RC, et al. Pediatric orbital floor fracture: direct extraocular muscle involvement. Ophthalmology. 2000;107:1875–1879.
Lane K, Penne RB, Bilyk JR. Evaluation and management of pediatric orbital fractures in primary care setting. Orbit. 2007;26(3):183–191.
Michael JG, Hug D, Dowd MD. Management of corneal abrasion in children: a randomized clinical trial. Ann Emerg Med. 2002;40:67–72.
Morad Y, Avni I, Benton SA, et al. Normal computerized tomography of brain in children with shaken baby syndrome. J AAPOS. 2004;8:445–450.
Petrou P, Patwary S, Banerjee PJ, et al. Bilateral macular hole from a handheld laser pointer. Lancet. 2014;383:1780–1781.
Smith GA, Knapp JF, Barnett TM, et al. The rocket’s red glare, the bombs bursting in air: fireworks-related injuries to children. Pediatrics. 1996;98:1–9.
Xu K, Chin EK, Quiram PA, et al. Retinal injury secondary to laser pointers in pediatric patients. Pediatrics. 2016;138(4):pii: e20161188. [Epub 2016 Sep 1].
Труды отечественных авторов при подготовке статей по педиатрии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.